title: T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells.
authors.forename: K
authors.initials: K
authors.lastname: Mihara
authors.forename: J
authors.initials: J
authors.lastname: Bhattacharyya
authors.forename: A
authors.initials: A
authors.lastname: Kitanaka
authors.forename: K
authors.initials: K
authors.lastname: Yanagihara
authors.forename: T
authors.initials: T
authors.lastname: Kubo
authors.forename: Y
authors.initials: Y
authors.lastname: Takei
authors.forename: H
authors.initials: H
authors.lastname: Asaoku
authors.forename: Y
authors.initials: Y
authors.lastname: Takihara
authors.forename: A
authors.initials: A
authors.lastname: Kimura
mesh_terms: D051997:ADP-ribosyl Cyclase 1 / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy; D008562:Membrane Glycoproteins / Q000276:immunology*; D009101:Multiple Myeloma / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
chemical_list: D008562:Membrane Glycoproteins; C498154:CD38 protein, human; D051997:ADP-ribosyl Cyclase 1